Post transplant anemia (PTA) is a common issue in kidney transplant recipients. Most
importantly it is associated with an impaired allograft function. Other important factors …

Cytomegalovirus (CMV) infection complicates the post‐operative course of patients
receiving solid organ transplants. While ganciclovir has significantly reduced the direct …

Abstract The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice
guideline on the monitoring, management, and treatment of kidney transplant recipients is …

Organ transplantation has been known for many years, but the introduction of drug regimens
using azathioprine and corticosteroids in 1960 and cyclosporine in 1980 meant a great …

BACKGROUND: Cytomegalovirus (CMV) infection and disease are major causes of
morbidity and mortality after renal transplantation. However, the incidence and potential risk …

Proper identification of active cytomegalovirus (CMV) and Epstein-Barr virus (EBV)
infections are helpful for monitoring antiviral treatment in transplant recipients. Qualitative …

Background: Cytomegalovirus (CMV) disease is an important cause of death and possibly
transplant rejection in kidney transplant (KT) patients. This study was conducted to …

Background Anemia is a very common occurrence in post-renal transplant patients. Post-
transplantation anemia (PTA) is associated with significant graft loss or cardiovascular …

Objective: This study assessed incidence, severity, and time to occurrence of drug-induced
leukopenia/thrombocytopenia within 1 st month after kidney transplantation. Methods: This …

Recipients of renal allografts are surviving longer and, consequently, may experience a
variety of complications related not only to the transplanted kidney, but also to the …